The use of interferon alpha-C in patients with metastatic renal cell carcinoma arising in a congenital solitary kidney.
Three cases of renal cell carcinoma in a congenital solitary kidney are presented. Treatment with recombinant interferon alpha-C was administered in two cases. A subjective response occurred in one case. The literature is reviewed with respect to treatment options and prognostic factors.
Merimsky
O
O
Department of Oncology, Ichilov Hospital, Tel-Aviv Sourasky Medical Center, Israel.
Merimsky
E
E
Chaitchik
S
S
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007668:Kidney / Q000002:abnormalities*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins